AcbaC.17275.a
2,3-bisphosphoglycerate-independent phosphoglycerate mutase
CENTER ID:
AcbaC.17275.a
ORGANISM:
Acinetobacter baumannii AB5075-UW
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
unclassified
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
AcbaC.17275.a.B1.GE38749
full length
info
1
515
AcbaC.17275.a.B1.GE38749
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
AcbaC.17275.a.B1.PS02383
full length
info
1
515
PS02383
AcbaC.17275.a.B1.PS38071
full length
info
1
515
PS38071
Structures
5VPU
DEPOSITED: 5/5/2017
DETERMINATION: XRay
CLONE: AcbaC.17275.a.B1.GE38749
PROTEIN: AcbaC.17275.a.B1.PS38071
Publications by SSGCID
Toward a structome of Acinetobacter baumannii drug targets
Abendroth J, Barrett LK, Dranow DM, Edwards TE, Lorimer DD, Myler PJ, Phan I, Staker B, Subramanian S, Van Voorhis WC, Craig JC, Chun IKH, Barrett KF, Prentice RA, Tillery L, Shek P
Protein Sci. - 2020
volume 29, issue 3, pages 789-802
PDB:
4YL5 ,
4YWR ,
4ZIY ,
4ZJU ,
4ZN6 ,
4ZR8 ,
5BT8 ,
5CC8 ,
5CM7 ,
5CY4 ,
5DD7 ,
5E3I ,
5EKS ,
5EO6 ,
5HA4 ,
5IDV ,
5J3B ,
5KHA ,
5U7S ,
5UDF ,
5URB ,
5VMB ,
5VMK ,
5VPU ,
6AMY ,
6AMZ ,
6BNG ,
6BQY ,
6BQZ ,
6C49 ,
6CAU ,
6D6K ,
6MFM ,
6MPR ,
6MRF
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MTDATAGKIP HVLVIMDGVG HREAIEDNAF LAAKTPNLTA MKAKHPNSLI SGSGEDVGLP DGQMGNSEVG HMNLGAGRVL YQDFTRITKD IRTGAFFEHE VLVDAVEKAK AAGGAVHIMG LLSEGGVHSH EDHIVAMCEL ALKRGAKVYL HAFLDGRDTP PRSAQPSLEK LDALFAQYEG KGRIATMIGR YFAMDRDNRW DRVEQAYRLL TEGEAVRTAT TAVEGLELAY AANENDEFVK ATRIGEIAKV QDGDSVVFMN FRADRAREIT RAFVEKDFAG FERKVVPNLS KFVMLTRYQA SIDAPVAYMP EELKNSLGEY LSSLGKTQLR IAETEKYAHV TFFFSGGRED EYPGEKRILI PSPNVATYDL KPEMSAYEVT DELVKAINSG EYDLLVVNYA NGDMVGHTGV FDAAVKAVEA VDTCLGRVYE AVMAKKGHML ITADHGNVEQ MQDYESGQVH TQHTTELVPF IYVGPTQATI AEGGVLADVA PTILNLMQIP VPAEMQGRNL ITLSA
NT Sequence
ATGACGGATG CAACTGCTGG CAAGATCCCT CACGTTCTGG TCATTATGGA TGGTGTTGGA CACCGTGAAG CGATTGAAGA TAATGCTTTT CTTGCAGCAA AAACCCCGAA TTTAACTGCA ATGAAAGCAA AGCATCCAAA TAGTCTCATT TCTGGTTCTG GTGAAGATGT TGGTTTACCT GATGGACAAA TGGGTAACTC TGAAGTTGGT CACATGAACC TTGGCGCTGG CCGAGTGTTA TACCAAGACT TCACACGTAT TACTAAAGAT ATTCGTACTG GTGCTTTTTT TGAACACGAA GTATTGGTTG ATGCCGTAGA AAAAGCAAAA GCAGCGGGTG GCGCAGTTCA TATTATGGGC CTACTCTCTG AAGGCGGTGT TCACTCACAT GAAGATCATA TTGTGGCGAT GTGTGAACTT GCCTTAAAAC GCGGTGCGAA AGTTTACTTA CATGCATTCC TTGATGGTCG TGATACTCCT CCACGTAGTG CTCAACCTTC ATTAGAAAAA TTAGATGCTT TATTCGCTCA ATATGAAGGC AAGGGCCGTA TTGCAACCAT GATTGGTCGC TATTTTGCAA TGGATCGTGA TAACCGTTGG GATCGTGTTG AGCAGGCTTA CCGTTTATTA ACGGAAGGTG AAGCTGTTCG TACTGCAACT ACTGCGGTTG AAGGCTTAGA GCTTGCATAT GCTGCAAATG AAAATGATGA GTTTGTAAAA GCAACCCGTA TTGGTGAGAT CGCTAAAGTT CAAGATGGCG ATAGCGTTGT ATTTATGAAT TTCCGTGCTG ACCGTGCCCG TGAAATTACG CGTGCGTTTG TTGAAAAAGA TTTCGCAGGT TTTGAGCGTA AAGTTGTACC GAACCTTTCT AAATTTGTCA TGTTGACGCG TTATCAGGCA AGTATTGATG CACCTGTGGC ATATATGCCT GAAGAGTTAA AGAACTCGCT TGGTGAATAT TTATCTTCTT TAGGTAAAAC GCAATTACGT ATTGCTGAAA CTGAGAAATA TGCCCATGTG ACTTTCTTCT TTAGTGGTGG TCGTGAAGAC GAATATCCAG GTGAAAAGCG TATTTTAATT CCATCGCCAA ACGTTGCGAC ATATGACTTA AAGCCTGAAA TGAGTGCTTA TGAAGTAACT GATGAGCTAG TCAAAGCAAT TAACTCGGGT GAGTACGACT TACTTGTTGT GAACTATGCC AATGGTGATA TGGTCGGTCA TACAGGCGTA TTTGATGCTG CAGTTAAGGC TGTTGAAGCA GTTGATACAT GTTTAGGTCG TGTATACGAA GCTGTAATGG CGAAAAAAGG CCATATGCTT ATTACGGCTG ACCACGGTAA TGTTGAACAA ATGCAAGATT ATGAAAGTGG TCAGGTTCAT ACTCAGCATA CAACAGAGCT TGTGCCTTTT ATTTATGTGG GTCCAACCCA AGCAACGATT GCAGAAGGTG GCGTGCTTGC TGATGTTGCA CCGACCATTC TGAACTTAAT GCAGATTCCT GTGCCTGCTG AAATGCAAGG TCGTAATCTC ATTACATTGT CTGCTTAA
Details for AcbaC.17275.a.B1.GE38749
HARVESTED ON:
1/22/2015
SEQUENCED ON:
1/15/2015
EXPECTED MW:
57kDa
OBSERVED MW:
57kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98
Details for AcbaC.17275.a.B1.PS02383
PURIFICATION DATe:
4/21/2015
CONCENTRATION:
29mg/ml
OBSERVED MW:
62kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
20 mM HEPES, pH 7.0, 300 mM NaCl, 5% glycerol and 1 mM TCEP
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
7
VIAL VOLUME:
200µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98
Details for AcbaC.17275.a.B1.PS38071
PURIFICATION DATe:
10/11/2016
CONCENTRATION:
24.7mg/ml
OBSERVED MW:
68kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
SEC
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
7
VIAL VOLUME:
100µl
PERCENT IDENTITY:
100
PERCENT COVERAGE:
98